IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

NQ Hcif GP, Ltd.

Q1 2016 Holdings

Filed 2016-04-25 | 1 holdings | $54.1K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Revance Therapeutics, Inc.(RVNCEUR)COM761330109$54.1K3,096,650100.0%